SCHOTT Pharma AG & Co. KGaA Sustainability Profile
SCHOTT Pharma AG & Co. KGaA, a leading global provider of pharmaceutical packaging solutions, is headquartered in Germany. Established in 1884, the company has evolved into a key player in the pharmaceutical and healthcare industries, with significant operations across Europe, North America, and Asia. Specialising in high-quality glass and polymer packaging, SCHOTT Pharma offers a diverse range of products, including vials, syringes, and ampoules, designed to ensure the safety and efficacy of medications. Their commitment to innovation and sustainability sets them apart in a competitive market. With a strong focus on customer-centric solutions, SCHOTT Pharma has achieved notable milestones, including advancements in drug delivery systems and a robust portfolio that caters to the evolving needs of the pharmaceutical sector. Their reputation for excellence positions them as a trusted partner for pharmaceutical companies worldwide.
DitchCarbon Score
How does SCHOTT Pharma AG & Co. KGaA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Glass Products industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SCHOTT Pharma AG & Co. KGaA's score of 49 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
SCHOTT Pharma AG & Co. KGaA's reported carbon emissions
In 2024, SCHOTT Pharma AG & Co. KGaA reported total carbon emissions of approximately 27,536,000 kg CO2e for Scope 1, 43,941,000 kg CO2e for Scope 2, and a significant 398,000,000 kg CO2e for Scope 3 emissions. The Scope 3 emissions include categories such as purchased goods and services (212,000,000 kg CO2e) and capital goods (48,000,000 kg CO2e). In 2023, the company recorded similar emissions, with Scope 1 at about 30,226,000 kg CO2e, Scope 2 at 43,587,000 kg CO2e, and Scope 3 at 418,000,000 kg CO2e. SCHOTT Pharma has set ambitious climate commitments, aiming for an absolute reduction of 46.2% in Scope 1 and Scope 2 greenhouse gas emissions by 2030, with the baseline year being 2021. This target reflects the company's proactive approach to mitigating its carbon footprint and aligns with industry standards for climate action. The emissions data is cascaded from its parent company, SCHOTT AG, indicating a structured approach to sustainability across its corporate family. The company is currently on track to meet its near-term reduction targets, demonstrating a commitment to environmental responsibility within the pharmaceutical sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 30,226,000 | 00,000,000 |
| Scope 2 | 43,587,000 | 00,000,000 |
| Scope 3 | 418,000,000 | 000,000,000 |
How Carbon Intensive is SCHOTT Pharma AG & Co. KGaA's Industry?
How Carbon Intensive is SCHOTT Pharma AG & Co. KGaA's Location?
SCHOTT Pharma AG & Co. KGaA's Scope 3 Categories Breakdown
SCHOTT Pharma AG & Co. KGaA's Scope 3 emissions, which decreased by 5% last year and decreased by approximately 5% since 2023, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 53% of Scope 3 emissions.
Top Scope 3 Categories
SCHOTT Pharma AG & Co. KGaA's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
SCHOTT Pharma AG & Co. KGaA has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
